Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 12, 1998, Pages 2657-2668

  De Groot, Mark C H ^a   Illing, Barbara ^a   Horn, Michael ^a   Urban, Bert ^a   Haase, Axel ^a   Schnackerz, Klaus ^b   Neubauer, Stefan ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Coronary circulation; Endothelins; Ischemia reperfusion injury; NMR spectroscopy; Rat

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; ENDOTHELIN 1; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON; BLOOD FLOW VELOCITY; CELL PH; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE PREDISPOSITION; ENERGY METABOLISM; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALIA;

EID: 0032415548     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0822     Document Type: Article

References (48)

1. AHMED SA, WILLIAMSON JE, ROBERTS RE, CLARKE RE, SOBEL BE, 1976. The association of increased plasma M.B CPK activity and irreversible ischemic myocardial injury in the dog. Circulation 54: 187-193.
2. ALLEN DG, ORCHARD CH, 1987. Myocardial contractile function during ischemia and hypoxia. Circ Res 60: 153-168.
3. BEYER ME, NERZ S, KRÄMER BK, HOFFMEISTER HM, 1994. Hemodynamic and inotropic effects of endothelin-1 in vivo. Basic Res Cardiol 89: 39-49.
4. BRUNNER F, DU TOIT EF, OPIE LH, 1992. Endothelin release during ischemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol 24: 1291-1305.
5. 31P nuclear magnetic resonance spectroscopy. J Mol Cell Cardiol 19: 1153-1160.
6. DAGASSAN PH, BREU V, CLOZEL M, CLOZEL J-P, 1994. Role of endothelin during reperfusion after ischemia in isolated perfused rat heart. J Cardiovasc Pharmacol 24: 867-874.
7. GROSS WL, BAK MI, INGWALL JS, ARSTALL MA, SMITH TW, BALLIGAND JL, KELLY RA, 1996. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc Natl Acad Sci USA 93: 5604-5609.
8. HAN H, NEUBAUER S, BRAEKER B, ERTL G, 1995. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart-attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610. J Mol Cell Cardiol 27: 761-766.
9. HILAL-DANDAN R, URASAWA K, BRUNTON L, 1992. Endothelin inhibits adenylate cyclase and stimulates phosphoinositide hydrolysis in adult cardiac myocytes. J Biol Chem 267: 10620-10624.
10. HOGG N, SINGH RJ, KALYANARAMAN B, 1996. The role of glutathione in the transport and catabolism of nitric oxide. FEBS Lett 382: 223-228.
11. HU JR, VON HARSDORF R, LANG RE, 1988. Endothelin has potent inotropic effects in rat atria. Eur J Pharmacol 158: 275-278.
12. ILLING B, HORN M, HAN H, HAHN S, BUREIK P, ERTL G, NEUBAUER S, 1996. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat heart. J Cardiovasc Pharmacol 27: 487-494.
13. INGWALL JS, 1982. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol 242: H729-H744.
14. ISHIKAWA T, YANAGISAWA M, KIMURA S, GOTO K, MASAHI T, 1988. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 255: H970-H973.
15. KARMAZYN M, 1996. The sodium-hydrogen exchange system in the heart: its role in ischemic and reperfusion injury and therapeutic implications. Can J Cardiol 12: 1074-1082.
16. + exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts. Circ Res 75: 369-378.
17. + exchanger. Circ Res 68: 269-279.
18. KUSUMOTO K, AWANE Y, FUJIWARA S, WATANABE T, 1993. Role of endogenous endothelin in extension of rabbit myocardial infarction. J Cardiovasc Pharmacol 22: S339-S342.
19. 2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes. J Physiol 448: 729-747.
20. LEVIN ER, 1995. Mechanisms of disease; Endothelins. N Engl J Med 333: 356-363.
21. LI XS, WANG QD, PERNOW J, 1995. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. Eur J Pharmacol 283: 161-168.
22. LÜSCHER TF, 1991. Endothelin. J Cardiovasc Pharmacol 18: S15-S22.
23. LÜSCHER TF, 1993. The endothelium as a target and mediator of cardiovascular disease. Eur J Clin Invest 23: 670-685.
24. MALATINO L, GRASSI R, STANCANELLI B, POLIZZI G, LEONARDI C, TAMBURINO G, 1993. Release of immunoreactive endothelin from the heart during percutaneous transluminal coronary angioplasty. Am Heart J 126: 700-702.
25. MCMURDO L, CORDER R, THIEMERMANN C, VANE JR, 1993. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol 108: 557-561.
26. 2+ current: involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268: 26286-26295.
27. 31P magnetic resonance. J Biol Chem 248: 7276-7278.
28. NAYLER WG, 1990. The Endothelins. Springer Verlag, Berlin.
29. NEUBAUER S, ERTL G, HAAS U, PULZER F, KOCHSIEK K, 1990a. Effects of endothelin-1 in isolated perfused rat heart. J Cardiovasc Pharmacol 16: 1-8.
30. NEUBAUER S, ERTL G, PULZER F, HAAS U, HIRSCH A, ZIMMERMANN S, KOCHSIEK K, 1990b. Effects of endothelin-1 in the isolated heart under ischemic and cardioplegic conditions. J Cardiovasc Pharmacol 16: 804-811.
31. NEUBAUER S, ZIMMERMANN S, HIRSCH A, PULZER F, TIAN R, BAUER W, BAUER B, ERTL G, 1991. Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. J Mol Cell Cardiol 23: 1397-1409.
32. NEUBAUER S, HORN M, NAUMANN A, TIAN R, HU K, LASER M, FRIEDRICH J, GAUDRON P, SCHNACKERZ K, INGWALL JS, ERTL G, 1995. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest 95: 1092-1100.
33. DE NUCCI G, THOMAS R, D'ORLEANS-JUSTE P, ANTUNES E, WALDER C, WARNER TD, VANE JR, 1988. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797-9800.
34. PABLA R, CURTIS MJ, 1996. Effects of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart. J Mol Cell Cardiol 28: 2111-2121.
35. POLLOCK DM, DIVISH BJ, OPGENORTH TJ, 1993. Stimulation of endogenous endothelin release in the anesthetized rat. J Cardiovasc Pharmacol 22: S295-S298.
36. RICHARD V, KAEFFER N, HOGIE M, TRON C, BLANC T, THUILLEZ C, 1994. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ET A-ET B antagonist. Br J Pharmacol 113: 869-876.
37. SALZMAN AL, MENCONI MJ, UNNO N, EZZEL RM, CASEY DM, GONZALEZ PK, FINK MP, 1995. Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 268: G361-G373.
38. SIMONSON MS, DUNN MJ, 1990. Endothelin; Pathways of transmembrane signaling. Hypertension 15: I-5-I-12.
39. + exchange, c-fos expression and mitogenesis in rat mesangial cells. J Clin Invest 83: 708-712.
40. STEWART DJ, KUBAC G, COSTELLO KB, CERNACEK P, 1991. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18: 38-43.
41. SUZUKI T, KUMAZAKI T, MITSUI Y, 1993. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 191: 823-830.
42. TAKANASHI M, ENDOH M, 1991. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 261: H611-H619.
43. TONNESSEN T, GIAID A, SALEH D, NAESS PA, YANAGISAWA M, CHRISTENSEN G, 1995. Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 76: 767-772.
44. 2+ from a caffeine- and ryanodine-sensitive intracellular pool in rat atrial cells. J Biol Chem 265: 6782-6787.
45. WANG QD, LI XS, PERNOW J, 1995. The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart. J Cardiovasc Pharmacol 26 Suppl 3: S445-S447.
46. WATANABE T, SUZUKI N, SHIMAMOTO N, FUJINO M, IMADA A, 1991. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 69: 370-377.
47. YANAGISAWA M, KURIHARA S, TOMOBE Y, KOBAJASHI M, MITZUI Y, GOTO K, MASAHI T, 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
48. ZAR ZH, 1974. Biostatistical Analysis. Prentice Hall, Englewood Cliffs, NJ.